Skip to Content


In the US, Sorafenib (sorafenib systemic) is a member of the following drug classes: multikinase inhibitors, VEGF/VEGFR inhibitors and is used to treat Hepatic Tumor, Hepatocellular Carcinoma, Renal Cell Carcinoma and Thyroid Cancer.

US matches:



ATC (Anatomical Therapeutic Chemical Classification)


CAS registry number (Chemical Abstracts Service)


Chemical Formula


Molecular Weight


Therapeutic Categories

Cytostatic agent

Angiogenesis inhibitor

Tyrosine kinase inhibitor

Chemical Names

4-(4-{3-[4-Chloro-3-(trifluorometyl)phenyl]ureido}phenoxy)-N²-metylpyridine-2-carboxamide (WHO)

4-{4-[3-(4-Chlor-3-trifluormetylphenyl)ureido]phenoxy}pyridin-2-carbonsäuremetylamid (IUPAC)

Foreign Names

  • Sorafenibum (Latin)
  • Sorafenib (German)
  • Sorafénib (French)
  • Sorafenib (Spanish)

Generic Names

Brand Names

  • Nexavar
    Bayer, Bosnia & Herzegowina; Bayer, China; Bayer, Egypt; Bayer, Hong Kong; Bayer, Lebanon; Bayer, Turkey; Bayer HealthCare, Singapore; Bayer Schering, Taiwan; Bayer Thai Co Ltd, Thailand; Bayer, Belgium; Bayer, Canada; Bayer, Chile; Bayer, Colombia; Bayer, Denmark; Bayer, Ecuador; Bayer, Spain; Bayer, United Kingdom; Bayer, Greece; Bayer, Croatia (Hrvatska); Bayer, Hungary; Bayer, Ireland; Bayer, Italy; Bayer, Latvia; Bayer, Netherlands; Bayer, New Zealand; Bayer, Oman; Bayer, Philippines; Bayer, Poland; Bayer, Portugal; Bayer, Romania; Bayer, Sweden; Bayer, Slovakia; Bayer Health Care, Malaysia; Bayer HealthCare, Finland; Bayer HealthCare, Russian Federation; Bayer HealthCare, United States; Bayer Pharma, Austria; Bayer Pharma AG, Norway; Bayer Santé, France; Bayer Schering, Australia; Bayer Schering, Czech Republic; Bayer Schering, Lithuania; Bayer Schering, Serbia; Bayer Schering, South Africa; Bayer Vital, Germany; Bayer Yakuhin, Japan; Bayer-Schering, Iceland; Emra-Med Arzneimittel, Austria; Eurim-Pharm, Austria; Haemato Pharm, Austria; Orifarm, Norway


BANBritish Approved Name
BANMBritish Approved Name (Modified)
IUPACInternational Union of Pure and Applied Chemistry
ISInofficial Synonym
JANJapanese Accepted Name
OSOfficial Synonym
Rec.INNRecommended International Nonproprietary Name (World Health Organization)
USANUnited States Adopted Name
WHOWorld Health Organization

Further information on drug naming conventions: International Nonproprietary Names.

Important Notice: The international database is in BETA release. This means it is still under development and may contain inaccuracies. It is not intended as a substitute for the expertise and judgement of your physician, pharmacist or other healthcare professional. It should not be construed to indicate that the use of any medication in any country is safe, appropriate or effective for you. Consult with your healthcare professional before taking any medication.

Further information

Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.